A biocompatible hydrogel that rapidly solidifies upon contact with body fluids, designed for wound closure, hemostasis, and tissue sealing applications in surgical and emergency care settings. The technology enables immediate mechanical stabilization without requiring additional activation steps.
Manufactured by
Gellycle Co., Ltd.
Tokyo, Japan
Gellycle is a bio startup originating from the University of Tokyo, established in 2018 with the goal of revolutionizing medicine using Tetra-gel which is the world's only homogeneous gel. By using Tetragel technology, we create various medical and industrial products such as hemostatic agents, anti-adhesion materials, nerve regeneration materials, ophthalmic surgery aids, soil water retention materials for agriculture, and new electrode components. <Current Pipelines that we are seeking for> •Controlled Drug Delivery (AAV, etc.) •Iontophoresis for Type 1 Diabetes •Tendon Regeneration & Anti-Adhesion Material •Fat, Bone & Nerve Regeneration Material •Hydrorelease & Ophthalmic Viscoelastic Device •Artificial Ligament and Gel Thread •Dental application (Gum regeneration, wound healing) •Wound Dressing or New Culture Medium (3D) • Eco-Friendly Super Absorbent Polymer <Achievement> •Winner of the ICC Summit KYOTO 2021 Real Tech Catapult. •University Venture Award 2023 University Venture Award Special Prize. •Selected for Berkeley SkyDeck, the world's top accelerator.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Jiangxi Borayer Biotechnology Co., Ltd
China · 6 relevant products
INCORE Co.,Ltd.
South Korea · 1 relevant product
MEDPLUS FRANCE SAS
France · 1 relevant product
76 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 110 closest product alternatives
Jiangxi Borayer Biotechnology Co., Ltd · China
The first domestic absorbable hemostatic fluid material developed for clinical use. This product is designed to control bleeding through absorption and hemostatic action.
Jiangxi Borayer Biotechnology Co., Ltd · China
A hemostatic membrane derived from biological materials for controlling bleeding. It provides effective hemostasis through biological fluid interaction.
INCORE Co.,Ltd. · South Korea
It is a hemostatic product made by deacetylating chitin extracted from natural materials such as crustaceans to enhance the hemostatic effect and is made from a crustacean-free allergic reaction. It has many advantages such as hemostatic properties, biocompatibility, high absorbency, and antibacterial properties. It increases the cohesiveness of blood fluid by contacting the anions of chitosan and blood, promotes fibrin production, and has a rapid hemostatic mechanism by platelet coagulation. Unlike general hemostatic agents, when removing the gauze after stopping the bleeding, if you pour saline solution or water on the wound, a gelling phenomenon occurs on the gauze surface, preventing secondary bleeding that occurs when removing it. It is divided into a gauze type used for general wounds and a tampon type used for treating female diseases.
107 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products